MX2020003080A - Métodos para inhibir la conversión de colina en trimetilamina (tma). - Google Patents

Métodos para inhibir la conversión de colina en trimetilamina (tma).

Info

Publication number
MX2020003080A
MX2020003080A MX2020003080A MX2020003080A MX2020003080A MX 2020003080 A MX2020003080 A MX 2020003080A MX 2020003080 A MX2020003080 A MX 2020003080A MX 2020003080 A MX2020003080 A MX 2020003080A MX 2020003080 A MX2020003080 A MX 2020003080A
Authority
MX
Mexico
Prior art keywords
tma
trimethylamine
choline
methods
inhibiting conversion
Prior art date
Application number
MX2020003080A
Other languages
English (en)
Inventor
Michael Reilly
Jose Carlos Garcia-Garcia
George Franklin Gerberick
Stanley Leon HAZEN
Xiaodong Gu
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of MX2020003080A publication Critical patent/MX2020003080A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/39—Heterocyclic compounds having sulfur as a ring hetero atom having oxygen in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Un método para inhibir la conversión de colina en trimetilamina (TMA) y reducir la TMAO en un individuo al proporcionar una composición que comprende un compuesto expuesto en la Fórmula (I): Fórmula (I). (ver Fórmula).
MX2020003080A 2017-10-02 2018-10-02 Métodos para inhibir la conversión de colina en trimetilamina (tma). MX2020003080A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762566975P 2017-10-02 2017-10-02
PCT/US2018/053924 WO2019070676A1 (en) 2017-10-02 2018-10-02 METHODS OF INHIBITING CONVERSION FROM CHOLINE TO TRIMETHYLAMINE (TMA)

Publications (1)

Publication Number Publication Date
MX2020003080A true MX2020003080A (es) 2022-02-18

Family

ID=63963526

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020003080A MX2020003080A (es) 2017-10-02 2018-10-02 Métodos para inhibir la conversión de colina en trimetilamina (tma).

Country Status (9)

Country Link
US (1) US10751301B2 (es)
EP (1) EP3522876B1 (es)
CN (1) CN111163763B (es)
AU (1) AU2018345747B2 (es)
BR (1) BR112020006108A2 (es)
CA (1) CA3076195C (es)
MX (1) MX2020003080A (es)
PL (1) PL3522876T3 (es)
WO (1) WO2019070676A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110959862B (zh) * 2019-11-14 2021-08-13 南方医科大学 一种具有清除氧化三甲胺和抗炎功能的组合物及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1542826B1 (de) 1966-06-01 1971-04-08 Basf Ag Sulfoniumverbindungen und deren Verwendung
FR1524922A (fr) * 1966-06-01 1968-05-10 Basf Ag Agents entravant la croissance et modifiant l'habitus des plantes
FR1559102A (es) 1968-01-23 1969-03-07
US3644531A (en) 1968-08-13 1972-02-22 Sankyo Co 2-propynylsulfonium salts
US3651222A (en) 1969-09-15 1972-03-21 Monsanto Co Nematocidal use of substituted dimethylsulfonium tetraphenylborates
DE2331185A1 (de) 1973-06-19 1975-01-16 Bayer Ag Mittel zur regulierung des pflanzenwachstums
EP0555058B1 (en) * 1992-02-07 1997-05-07 Toyo Ink Manufacturing Co., Ltd. (Oxo)sulfonium complex, polymerizable composition containing the complex, and method of polymerizing composition
JP4999043B2 (ja) * 2006-02-13 2012-08-15 株式会社Ａｄｅｋａ スルホニウム塩化合物、カチオン重合開始剤および熱硬化性組成物
EP2222220B1 (en) 2007-12-05 2016-03-16 The Cleveland Clinic Foundation Trimethylamine compounds as risk predictors of cardiovascular disease
CA2876177C (en) * 2012-06-11 2022-06-14 The Cleveland Clinic Foundation Treatment and prevention of cardiovascular disease and thrombosis
EP3383377B1 (en) 2015-12-01 2024-04-17 The Procter & Gamble Company Compounds and methods for inhibiting production of trimethylamine
AU2017291211B2 (en) 2016-06-29 2020-06-25 Cleveland Clinic Innovation Methods for inhibiting conversion of choline to trimethylamine (TMA)

Also Published As

Publication number Publication date
CA3076195A1 (en) 2019-04-11
PL3522876T3 (pl) 2021-06-28
CA3076195C (en) 2022-06-21
CN111163763B (zh) 2023-08-22
EP3522876B1 (en) 2021-02-24
AU2018345747A1 (en) 2020-04-09
US20190099384A1 (en) 2019-04-04
BR112020006108A2 (pt) 2020-09-24
AU2018345747B2 (en) 2021-03-18
US10751301B2 (en) 2020-08-25
CN111163763A (zh) 2020-05-15
EP3522876A1 (en) 2019-08-14
WO2019070676A1 (en) 2019-04-11

Similar Documents

Publication Publication Date Title
MX2018015938A (es) Metodos para inhibir la conversion de colina en trimetilamina (tma).
MX2020009347A (es) Picolinamidas como fungicidas.
MX2016011898A (es) Composiciones de compuestos selenoorganicos y metodos de uso de los mismos.
MX2016012829A (es) Inhibidores de biaril cinasa.
MX2017016819A (es) Composiciones antimicrobianas y sus usos.
BR112018010873A2 (pt) compostos e métodos para inibir a produção de trimetilamina
MX2016009352A (es) Inhibidores de quinasa a base de quinolina.
AU2015287674B2 (en) Topical antiviral compositions and methods of using the same
MX2022010755A (es) Inhibidores de quinasa y usos de los mismos.
MX2016005760A (es) Inhibidores de glucogeno sintasa cinasa 3 (gsk-3).
BR112017008176A2 (pt) método de preparação do carbonato de ácido glicérico.
PH12017500737B1 (en) Kcnq2-5 channel activator
MX2020003081A (es) Metodos para inhibir la conversion de colina en trimetilamina (tma).
MX2016002924A (es) Inhibidores de cinasa a base de eter arilico.
MX2016010973A (es) Compuestos de aminocarbonilcarbamato.
MX2017001901A (es) Aminas con bajo contenido de compuestos organicos volatiles (voc) como componente activo en superficie en dispersiones.
PH12019501722A1 (en) Compositions and methods for promoting hair growth with mpc1 inhibitors
NZ717098A (en) Vancomycin derivative, and preparation method and application thereof
JO3742B1 (ar) مركب بيرانو داي بيريدين
UA115583C2 (uk) Азетидинілоксифенілпіролідинові сполуки
IN2014MN01671A (es)
MX2020003082A (es) Metodos para inhibir la conversion de colina en trimetilamina (tma).
GB2547812A (en) Proppant composition and method
BR112018006005A2 (pt) composto bicíclico e uso do mesmo para inibição de suv39h2
BR112017011246A2 (pt) composições e métodos para introdução de micronutriente